Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444704973
总结
TPMT intermediate metabolizer phenotype is not associated with increased severity of Drug Toxicity when treated with mercaptopurine and methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma.